nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—pancreatic cancer	0.363	1	CbGaD
Betamethasone—CYP19A1—Tamoxifen—pancreatic cancer	0.145	0.386	CbGbCtD
Betamethasone—ABCB1—Tamoxifen—pancreatic cancer	0.0307	0.0817	CbGbCtD
Betamethasone—ABCB1—Gemcitabine—pancreatic cancer	0.0264	0.0704	CbGbCtD
Betamethasone—ABCB1—Erlotinib—pancreatic cancer	0.0261	0.0694	CbGbCtD
Betamethasone—ABCB1—Irinotecan—pancreatic cancer	0.0235	0.0627	CbGbCtD
Betamethasone—CYP3A4—Tamoxifen—pancreatic cancer	0.0184	0.0489	CbGbCtD
Betamethasone—ABCB1—Docetaxel—pancreatic cancer	0.0173	0.046	CbGbCtD
Betamethasone—ABCB1—Sunitinib—pancreatic cancer	0.0172	0.0457	CbGbCtD
Betamethasone—CYP3A4—Erlotinib—pancreatic cancer	0.0156	0.0416	CbGbCtD
Betamethasone—CYP3A4—Irinotecan—pancreatic cancer	0.0141	0.0376	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—pancreatic cancer	0.0129	0.0343	CbGbCtD
Betamethasone—CYP3A4—Docetaxel—pancreatic cancer	0.0103	0.0275	CbGbCtD
Betamethasone—CYP3A4—Sunitinib—pancreatic cancer	0.0103	0.0274	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—pancreatic cancer	0.00771	0.0205	CbGbCtD
Betamethasone—Increased appetite—Doxorubicin—pancreatic cancer	0.000182	0.000859	CcSEcCtD
Betamethasone—Affect lability—Epirubicin—pancreatic cancer	0.000182	0.000858	CcSEcCtD
Betamethasone—Migraine—Epirubicin—pancreatic cancer	0.000182	0.000858	CcSEcCtD
Betamethasone—Anorexia—Gemcitabine—pancreatic cancer	0.000181	0.000854	CcSEcCtD
Betamethasone—Dizziness—Erlotinib—pancreatic cancer	0.000181	0.000853	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000179	0.000844	CcSEcCtD
Betamethasone—Anorexia—Fluorouracil—pancreatic cancer	0.000178	0.000839	CcSEcCtD
Betamethasone—Hypotension—Gemcitabine—pancreatic cancer	0.000177	0.000837	CcSEcCtD
Betamethasone—Eye disorder—Docetaxel—pancreatic cancer	0.000177	0.000836	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000177	0.000834	CcSEcCtD
Betamethasone—Insomnia—Irinotecan—pancreatic cancer	0.000176	0.000832	CcSEcCtD
Betamethasone—Cardiac arrest—Epirubicin—pancreatic cancer	0.000176	0.000829	CcSEcCtD
Betamethasone—Vomiting—Tamoxifen—pancreatic cancer	0.000175	0.000829	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000175	0.000827	CcSEcCtD
Betamethasone—Mood swings—Epirubicin—pancreatic cancer	0.000175	0.000826	CcSEcCtD
Betamethasone—Paraesthesia—Irinotecan—pancreatic cancer	0.000175	0.000826	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—pancreatic cancer	0.000174	0.000824	CcSEcCtD
Betamethasone—Hypotension—Fluorouracil—pancreatic cancer	0.000174	0.000823	CcSEcCtD
Betamethasone—Rash—Tamoxifen—pancreatic cancer	0.000174	0.000822	CcSEcCtD
Betamethasone—Dermatitis—Tamoxifen—pancreatic cancer	0.000174	0.000821	CcSEcCtD
Betamethasone—Vomiting—Erlotinib—pancreatic cancer	0.000174	0.00082	CcSEcCtD
Betamethasone—Headache—Tamoxifen—pancreatic cancer	0.000173	0.000816	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000173	0.000816	CcSEcCtD
Betamethasone—Rash—Erlotinib—pancreatic cancer	0.000172	0.000813	CcSEcCtD
Betamethasone—Dermatitis—Erlotinib—pancreatic cancer	0.000172	0.000812	CcSEcCtD
Betamethasone—Angiopathy—Docetaxel—pancreatic cancer	0.000172	0.000812	CcSEcCtD
Betamethasone—Insomnia—Gemcitabine—pancreatic cancer	0.000172	0.00081	CcSEcCtD
Betamethasone—Dyspepsia—Irinotecan—pancreatic cancer	0.000171	0.000809	CcSEcCtD
Betamethasone—Headache—Erlotinib—pancreatic cancer	0.000171	0.000808	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000171	0.000807	CcSEcCtD
Betamethasone—Paraesthesia—Gemcitabine—pancreatic cancer	0.00017	0.000804	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00017	0.000802	CcSEcCtD
Betamethasone—Asthenia—Sunitinib—pancreatic cancer	0.00017	0.000801	CcSEcCtD
Betamethasone—Dry skin—Epirubicin—pancreatic cancer	0.000169	0.000799	CcSEcCtD
Betamethasone—Decreased appetite—Irinotecan—pancreatic cancer	0.000169	0.000799	CcSEcCtD
Betamethasone—Arrhythmia—Docetaxel—pancreatic cancer	0.000169	0.000799	CcSEcCtD
Betamethasone—Insomnia—Fluorouracil—pancreatic cancer	0.000169	0.000796	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—pancreatic cancer	0.000168	0.000794	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—pancreatic cancer	0.000168	0.000794	CcSEcCtD
Betamethasone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000168	0.000794	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000168	0.000794	CcSEcCtD
Betamethasone—Fatigue—Irinotecan—pancreatic cancer	0.000168	0.000793	CcSEcCtD
Betamethasone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000167	0.000791	CcSEcCtD
Betamethasone—Alopecia—Docetaxel—pancreatic cancer	0.000167	0.00079	CcSEcCtD
Betamethasone—Pruritus—Sunitinib—pancreatic cancer	0.000167	0.00079	CcSEcCtD
Betamethasone—Pain—Irinotecan—pancreatic cancer	0.000167	0.000786	CcSEcCtD
Betamethasone—Erythema—Docetaxel—pancreatic cancer	0.000165	0.000779	CcSEcCtD
Betamethasone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000165	0.000779	CcSEcCtD
Betamethasone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000164	0.000775	CcSEcCtD
Betamethasone—Nausea—Tamoxifen—pancreatic cancer	0.000164	0.000774	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000164	0.000773	CcSEcCtD
Betamethasone—Fatigue—Gemcitabine—pancreatic cancer	0.000164	0.000772	CcSEcCtD
Betamethasone—Muscular weakness—Epirubicin—pancreatic cancer	0.000163	0.000769	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000163	0.000767	CcSEcCtD
Betamethasone—Pain—Gemcitabine—pancreatic cancer	0.000162	0.000766	CcSEcCtD
Betamethasone—Nausea—Erlotinib—pancreatic cancer	0.000162	0.000766	CcSEcCtD
Betamethasone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000162	0.000765	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—pancreatic cancer	0.000162	0.000764	CcSEcCtD
Betamethasone—Diarrhoea—Sunitinib—pancreatic cancer	0.000162	0.000764	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000161	0.00076	CcSEcCtD
Betamethasone—Feeling abnormal—Irinotecan—pancreatic cancer	0.00016	0.000758	CcSEcCtD
Betamethasone—Pain—Fluorouracil—pancreatic cancer	0.000159	0.000753	CcSEcCtD
Betamethasone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000159	0.000752	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—pancreatic cancer	0.000157	0.00074	CcSEcCtD
Betamethasone—Dizziness—Sunitinib—pancreatic cancer	0.000156	0.000738	CcSEcCtD
Betamethasone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000156	0.000738	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000156	0.000734	CcSEcCtD
Betamethasone—Abdominal pain—Irinotecan—pancreatic cancer	0.000154	0.000727	CcSEcCtD
Betamethasone—Body temperature increased—Irinotecan—pancreatic cancer	0.000154	0.000727	CcSEcCtD
Betamethasone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000154	0.000726	CcSEcCtD
Betamethasone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000151	0.000712	CcSEcCtD
Betamethasone—Vomiting—Sunitinib—pancreatic cancer	0.00015	0.00071	CcSEcCtD
Betamethasone—Body temperature increased—Gemcitabine—pancreatic cancer	0.00015	0.000708	CcSEcCtD
Betamethasone—Rash—Sunitinib—pancreatic cancer	0.000149	0.000704	CcSEcCtD
Betamethasone—Dermatitis—Sunitinib—pancreatic cancer	0.000149	0.000703	CcSEcCtD
Betamethasone—Urticaria—Fluorouracil—pancreatic cancer	0.000148	0.0007	CcSEcCtD
Betamethasone—Headache—Sunitinib—pancreatic cancer	0.000148	0.000699	CcSEcCtD
Betamethasone—Syncope—Docetaxel—pancreatic cancer	0.000148	0.000698	CcSEcCtD
Betamethasone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000147	0.000696	CcSEcCtD
Betamethasone—Weight increased—Epirubicin—pancreatic cancer	0.000145	0.000686	CcSEcCtD
Betamethasone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000145	0.000684	CcSEcCtD
Betamethasone—Weight decreased—Epirubicin—pancreatic cancer	0.000144	0.000682	CcSEcCtD
Betamethasone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000144	0.00068	CcSEcCtD
Betamethasone—Convulsion—Docetaxel—pancreatic cancer	0.000143	0.000675	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—pancreatic cancer	0.000142	0.000672	CcSEcCtD
Betamethasone—Myalgia—Docetaxel—pancreatic cancer	0.00014	0.000663	CcSEcCtD
Betamethasone—Nausea—Sunitinib—pancreatic cancer	0.00014	0.000663	CcSEcCtD
Betamethasone—Asthenia—Irinotecan—pancreatic cancer	0.00014	0.00066	CcSEcCtD
Betamethasone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00014	0.000659	CcSEcCtD
Betamethasone—Conjunctivitis—Epirubicin—pancreatic cancer	0.000138	0.000653	CcSEcCtD
Betamethasone—Asthenia—Gemcitabine—pancreatic cancer	0.000136	0.000643	CcSEcCtD
Betamethasone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000135	0.000636	CcSEcCtD
Betamethasone—Oedema—Docetaxel—pancreatic cancer	0.000135	0.000636	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—pancreatic cancer	0.000134	0.000635	CcSEcCtD
Betamethasone—Pruritus—Gemcitabine—pancreatic cancer	0.000134	0.000634	CcSEcCtD
Betamethasone—Infection—Docetaxel—pancreatic cancer	0.000134	0.000631	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—pancreatic cancer	0.000134	0.000631	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000133	0.000629	CcSEcCtD
Betamethasone—Diarrhoea—Irinotecan—pancreatic cancer	0.000133	0.000629	CcSEcCtD
Betamethasone—Shock—Docetaxel—pancreatic cancer	0.000132	0.000625	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000132	0.000623	CcSEcCtD
Betamethasone—Pruritus—Fluorouracil—pancreatic cancer	0.000132	0.000623	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000132	0.000622	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—pancreatic cancer	0.000131	0.00062	CcSEcCtD
Betamethasone—Bradycardia—Epirubicin—pancreatic cancer	0.00013	0.000614	CcSEcCtD
Betamethasone—Diarrhoea—Gemcitabine—pancreatic cancer	0.00013	0.000613	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000129	0.00061	CcSEcCtD
Betamethasone—Dizziness—Irinotecan—pancreatic cancer	0.000129	0.000608	CcSEcCtD
Betamethasone—Haemoglobin—Epirubicin—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Betamethasone—Anorexia—Docetaxel—pancreatic cancer	0.000128	0.000606	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000128	0.000604	CcSEcCtD
Betamethasone—Haemorrhage—Epirubicin—pancreatic cancer	0.000128	0.000603	CcSEcCtD
Betamethasone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000128	0.000602	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—pancreatic cancer	0.000126	0.000594	CcSEcCtD
Betamethasone—Vomiting—Irinotecan—pancreatic cancer	0.000124	0.000585	CcSEcCtD
Betamethasone—Dizziness—Fluorouracil—pancreatic cancer	0.000123	0.000582	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—pancreatic cancer	0.000123	0.000581	CcSEcCtD
Betamethasone—Rash—Irinotecan—pancreatic cancer	0.000123	0.00058	CcSEcCtD
Betamethasone—Dermatitis—Irinotecan—pancreatic cancer	0.000123	0.000579	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000123	0.000579	CcSEcCtD
Betamethasone—Headache—Irinotecan—pancreatic cancer	0.000122	0.000576	CcSEcCtD
Betamethasone—Insomnia—Docetaxel—pancreatic cancer	0.000122	0.000575	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—pancreatic cancer	0.000121	0.000571	CcSEcCtD
Betamethasone—Vomiting—Gemcitabine—pancreatic cancer	0.000121	0.000569	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—pancreatic cancer	0.00012	0.000568	CcSEcCtD
Betamethasone—Rash—Gemcitabine—pancreatic cancer	0.00012	0.000565	CcSEcCtD
Betamethasone—Dermatitis—Gemcitabine—pancreatic cancer	0.000119	0.000564	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—pancreatic cancer	0.000119	0.000564	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000119	0.000561	CcSEcCtD
Betamethasone—Headache—Gemcitabine—pancreatic cancer	0.000119	0.000561	CcSEcCtD
Betamethasone—Vomiting—Fluorouracil—pancreatic cancer	0.000119	0.00056	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—pancreatic cancer	0.000118	0.000559	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000118	0.000558	CcSEcCtD
Betamethasone—Rash—Fluorouracil—pancreatic cancer	0.000118	0.000555	CcSEcCtD
Betamethasone—Dermatitis—Fluorouracil—pancreatic cancer	0.000117	0.000555	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—pancreatic cancer	0.000117	0.000552	CcSEcCtD
Betamethasone—Headache—Fluorouracil—pancreatic cancer	0.000117	0.000552	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000116	0.000549	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—pancreatic cancer	0.000116	0.000548	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—pancreatic cancer	0.000116	0.000547	CcSEcCtD
Betamethasone—Nausea—Irinotecan—pancreatic cancer	0.000116	0.000546	CcSEcCtD
Betamethasone—Pain—Docetaxel—pancreatic cancer	0.000115	0.000543	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—pancreatic cancer	0.000114	0.000539	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—pancreatic cancer	0.000114	0.000538	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—pancreatic cancer	0.000113	0.000533	CcSEcCtD
Betamethasone—Nausea—Gemcitabine—pancreatic cancer	0.000113	0.000532	CcSEcCtD
Betamethasone—Erythema—Epirubicin—pancreatic cancer	0.000111	0.000525	CcSEcCtD
Betamethasone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000111	0.000524	CcSEcCtD
Betamethasone—Nausea—Fluorouracil—pancreatic cancer	0.000111	0.000523	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—pancreatic cancer	0.000111	0.000522	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00011	0.00052	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—pancreatic cancer	0.000107	0.000507	CcSEcCtD
Betamethasone—Abdominal pain—Docetaxel—pancreatic cancer	0.000106	0.000502	CcSEcCtD
Betamethasone—Body temperature increased—Docetaxel—pancreatic cancer	0.000106	0.000502	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000106	0.000499	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—pancreatic cancer	0.000104	0.000493	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000103	0.000487	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—pancreatic cancer	0.000103	0.000486	CcSEcCtD
Betamethasone—Malaise—Epirubicin—pancreatic cancer	0.0001	0.000474	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—pancreatic cancer	9.99e-05	0.000472	CcSEcCtD
Betamethasone—Syncope—Epirubicin—pancreatic cancer	9.98e-05	0.000471	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—pancreatic cancer	9.78e-05	0.000462	CcSEcCtD
Betamethasone—Asthenia—Docetaxel—pancreatic cancer	9.66e-05	0.000456	CcSEcCtD
Betamethasone—Convulsion—Epirubicin—pancreatic cancer	9.64e-05	0.000455	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—pancreatic cancer	9.6e-05	0.000453	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.55e-05	0.000451	CcSEcCtD
Betamethasone—Pruritus—Docetaxel—pancreatic cancer	9.52e-05	0.00045	CcSEcCtD
Betamethasone—Myalgia—Epirubicin—pancreatic cancer	9.47e-05	0.000447	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—pancreatic cancer	9.44e-05	0.000446	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—pancreatic cancer	9.36e-05	0.000442	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—pancreatic cancer	9.28e-05	0.000438	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—pancreatic cancer	9.25e-05	0.000437	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—pancreatic cancer	9.23e-05	0.000436	CcSEcCtD
Betamethasone—Diarrhoea—Docetaxel—pancreatic cancer	9.21e-05	0.000435	CcSEcCtD
Betamethasone—Oedema—Epirubicin—pancreatic cancer	9.08e-05	0.000429	CcSEcCtD
Betamethasone—Anaphylactic shock—Epirubicin—pancreatic cancer	9.08e-05	0.000429	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—pancreatic cancer	9.05e-05	0.000427	CcSEcCtD
Betamethasone—Infection—Epirubicin—pancreatic cancer	9.02e-05	0.000426	CcSEcCtD
Betamethasone—Shock—Epirubicin—pancreatic cancer	8.93e-05	0.000422	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—pancreatic cancer	8.92e-05	0.000421	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—pancreatic cancer	8.9e-05	0.00042	CcSEcCtD
Betamethasone—Dizziness—Docetaxel—pancreatic cancer	8.9e-05	0.00042	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—pancreatic cancer	8.89e-05	0.00042	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—pancreatic cancer	8.89e-05	0.00042	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—pancreatic cancer	8.86e-05	0.000418	CcSEcCtD
Betamethasone—Hyperhidrosis—Epirubicin—pancreatic cancer	8.78e-05	0.000414	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—pancreatic cancer	8.76e-05	0.000414	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—pancreatic cancer	8.73e-05	0.000412	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—pancreatic cancer	8.66e-05	0.000409	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—pancreatic cancer	8.65e-05	0.000409	CcSEcCtD
Betamethasone—Vomiting—Docetaxel—pancreatic cancer	8.56e-05	0.000404	CcSEcCtD
Betamethasone—Rash—Docetaxel—pancreatic cancer	8.49e-05	0.000401	CcSEcCtD
Betamethasone—Hypotension—Epirubicin—pancreatic cancer	8.48e-05	0.000401	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—pancreatic cancer	8.48e-05	0.0004	CcSEcCtD
Betamethasone—Headache—Docetaxel—pancreatic cancer	8.43e-05	0.000398	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.4e-05	0.000397	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—pancreatic cancer	8.4e-05	0.000397	CcSEcCtD
Betamethasone—Infection—Doxorubicin—pancreatic cancer	8.35e-05	0.000394	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.27e-05	0.000391	CcSEcCtD
Betamethasone—Shock—Doxorubicin—pancreatic cancer	8.27e-05	0.00039	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—pancreatic cancer	8.24e-05	0.000389	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.23e-05	0.000388	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—pancreatic cancer	8.21e-05	0.000388	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—pancreatic cancer	8.2e-05	0.000387	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—pancreatic cancer	8.15e-05	0.000385	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.12e-05	0.000383	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—pancreatic cancer	8.01e-05	0.000378	CcSEcCtD
Betamethasone—Nausea—Docetaxel—pancreatic cancer	8e-05	0.000377	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—pancreatic cancer	7.99e-05	0.000377	CcSEcCtD
Betamethasone—Decreased appetite—Epirubicin—pancreatic cancer	7.89e-05	0.000373	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—pancreatic cancer	7.85e-05	0.000371	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.84e-05	0.00037	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—pancreatic cancer	7.83e-05	0.00037	CcSEcCtD
Betamethasone—Pain—Epirubicin—pancreatic cancer	7.76e-05	0.000367	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.65e-05	0.000361	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—pancreatic cancer	7.6e-05	0.000359	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—pancreatic cancer	7.54e-05	0.000356	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—pancreatic cancer	7.48e-05	0.000353	CcSEcCtD
Betamethasone—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.42e-05	0.000351	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—pancreatic cancer	7.39e-05	0.000349	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—pancreatic cancer	7.3e-05	0.000345	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.25e-05	0.000342	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—pancreatic cancer	7.24e-05	0.000342	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—pancreatic cancer	7.21e-05	0.000341	CcSEcCtD
Betamethasone—Pain—Doxorubicin—pancreatic cancer	7.18e-05	0.000339	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—pancreatic cancer	7.18e-05	0.000339	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—pancreatic cancer	7.18e-05	0.000339	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—pancreatic cancer	6.92e-05	0.000327	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.87e-05	0.000324	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—pancreatic cancer	6.67e-05	0.000315	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—pancreatic cancer	6.64e-05	0.000314	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—pancreatic cancer	6.64e-05	0.000314	CcSEcCtD
Betamethasone—Asthenia—Epirubicin—pancreatic cancer	6.51e-05	0.000308	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—pancreatic cancer	6.42e-05	0.000303	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—pancreatic cancer	6.21e-05	0.000293	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—pancreatic cancer	6.03e-05	0.000285	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—pancreatic cancer	6e-05	0.000283	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—pancreatic cancer	5.94e-05	0.000281	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—pancreatic cancer	5.77e-05	0.000273	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—pancreatic cancer	5.75e-05	0.000271	CcSEcCtD
Betamethasone—Rash—Epirubicin—pancreatic cancer	5.72e-05	0.00027	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—pancreatic cancer	5.72e-05	0.00027	CcSEcCtD
Betamethasone—Headache—Epirubicin—pancreatic cancer	5.69e-05	0.000269	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—pancreatic cancer	5.56e-05	0.000262	CcSEcCtD
Betamethasone—Nausea—Epirubicin—pancreatic cancer	5.39e-05	0.000255	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—pancreatic cancer	5.34e-05	0.000252	CcSEcCtD
Betamethasone—Rash—Doxorubicin—pancreatic cancer	5.3e-05	0.00025	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—pancreatic cancer	5.29e-05	0.00025	CcSEcCtD
Betamethasone—Headache—Doxorubicin—pancreatic cancer	5.26e-05	0.000248	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—pancreatic cancer	4.99e-05	0.000236	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—PPARG—pancreatic cancer	4.17e-05	0.000841	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CNR2—pancreatic cancer	4.16e-05	0.000839	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GLP1R—pancreatic cancer	4.16e-05	0.000839	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.15e-05	0.000835	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCKAR—pancreatic cancer	4.1e-05	0.000825	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—APOE—pancreatic cancer	4.07e-05	0.000821	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMP—pancreatic cancer	4.05e-05	0.000816	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	4.02e-05	0.00081	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAG2—pancreatic cancer	3.97e-05	0.0008	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	3.94e-05	0.000793	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MEN1—pancreatic cancer	3.91e-05	0.000788	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	3.9e-05	0.000786	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	3.89e-05	0.000784	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.86e-05	0.000777	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DTX1—pancreatic cancer	3.86e-05	0.000777	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.84e-05	0.000773	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	3.82e-05	0.000769	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.8e-05	0.000766	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SHH—pancreatic cancer	3.73e-05	0.000752	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	3.71e-05	0.000747	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IAPP—pancreatic cancer	3.69e-05	0.000743	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CG—pancreatic cancer	3.68e-05	0.000741	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SMAD4—pancreatic cancer	3.65e-05	0.000736	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	3.64e-05	0.000732	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PRSS1—pancreatic cancer	3.57e-05	0.000719	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.55e-05	0.000716	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—pancreatic cancer	3.55e-05	0.000715	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTHLH—pancreatic cancer	3.54e-05	0.000713	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTCH1—pancreatic cancer	3.54e-05	0.000713	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.53e-05	0.000711	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MEN1—pancreatic cancer	3.48e-05	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.4e-05	0.000685	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.38e-05	0.000681	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.34e-05	0.000673	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	3.33e-05	0.00067	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.31e-05	0.000667	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	3.3e-05	0.000664	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.28e-05	0.00066	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GLP1R—pancreatic cancer	3.26e-05	0.000658	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SST—pancreatic cancer	3.24e-05	0.000652	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.23e-05	0.000652	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CD—pancreatic cancer	3.23e-05	0.000651	CbGpPWpGaD
Betamethasone—PTGS2—Disease—DTX4—pancreatic cancer	3.23e-05	0.000651	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DPYD—pancreatic cancer	3.21e-05	0.000647	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	3.21e-05	0.000646	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.2e-05	0.000644	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAG1—pancreatic cancer	3.17e-05	0.000638	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	3.15e-05	0.000636	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	3.15e-05	0.000634	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PPP2R5B—pancreatic cancer	3.14e-05	0.000633	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ARG2—pancreatic cancer	3.1e-05	0.000624	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.08e-05	0.000621	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.05e-05	0.000615	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	3.05e-05	0.000615	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	3.05e-05	0.000614	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEY2—pancreatic cancer	3.03e-05	0.000609	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.02e-05	0.000607	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	3.01e-05	0.000607	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CNR1—pancreatic cancer	2.99e-05	0.000602	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.96e-05	0.000597	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.91e-05	0.000586	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.89e-05	0.000581	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GCG—pancreatic cancer	2.89e-05	0.000581	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EZH2—pancreatic cancer	2.87e-05	0.000577	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CB—pancreatic cancer	2.82e-05	0.000568	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	2.8e-05	0.000565	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEY1—pancreatic cancer	2.8e-05	0.000564	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—pancreatic cancer	2.79e-05	0.000562	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGTR1—pancreatic cancer	2.75e-05	0.000555	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STK11—pancreatic cancer	2.71e-05	0.000547	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMP—pancreatic cancer	2.71e-05	0.000545	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH1—pancreatic cancer	2.69e-05	0.000543	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	2.66e-05	0.000535	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.66e-05	0.000535	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.65e-05	0.000534	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.65e-05	0.000534	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.6e-05	0.000523	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.6e-05	0.000523	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—pancreatic cancer	2.54e-05	0.000512	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.53e-05	0.00051	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAG2—pancreatic cancer	2.48e-05	0.0005	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.47e-05	0.000498	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.45e-05	0.000494	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MEN1—pancreatic cancer	2.45e-05	0.000493	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—pancreatic cancer	2.44e-05	0.000491	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A2—pancreatic cancer	2.43e-05	0.00049	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.41e-05	0.000486	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—pancreatic cancer	2.38e-05	0.000479	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SMAD4—pancreatic cancer	2.38e-05	0.000479	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD44—pancreatic cancer	2.36e-05	0.000475	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.35e-05	0.000473	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SHH—pancreatic cancer	2.34e-05	0.000471	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.32e-05	0.000468	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HES1—pancreatic cancer	2.32e-05	0.000467	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.31e-05	0.000465	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IAPP—pancreatic cancer	2.31e-05	0.000465	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.29e-05	0.000461	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.26e-05	0.000456	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GCG—pancreatic cancer	2.26e-05	0.000456	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.25e-05	0.000454	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.23e-05	0.00045	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HSPA1B—pancreatic cancer	2.21e-05	0.000446	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ARG2—pancreatic cancer	2.19e-05	0.000442	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GLP1R—pancreatic cancer	2.18e-05	0.000439	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.18e-05	0.000439	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DPYD—pancreatic cancer	2.15e-05	0.000432	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—STK11—pancreatic cancer	2.13e-05	0.000428	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	2.11e-05	0.000426	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.1e-05	0.000423	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.05e-05	0.000412	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2.04e-05	0.00041	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TERT—pancreatic cancer	2.03e-05	0.00041	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.01e-05	0.000406	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2e-05	0.000402	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAG1—pancreatic cancer	1.98e-05	0.000399	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.94e-05	0.000392	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—pancreatic cancer	1.94e-05	0.000392	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSC2—pancreatic cancer	1.94e-05	0.000391	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMP—pancreatic cancer	1.92e-05	0.000386	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—pancreatic cancer	1.9e-05	0.000382	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD44—pancreatic cancer	1.88e-05	0.000379	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.88e-05	0.000379	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.88e-05	0.000378	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HSPA1A—pancreatic cancer	1.87e-05	0.000377	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—pancreatic cancer	1.86e-05	0.000375	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.84e-05	0.000371	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.84e-05	0.000371	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMS—pancreatic cancer	1.83e-05	0.000369	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.77e-05	0.000357	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	1.77e-05	0.000356	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.75e-05	0.000353	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	1.75e-05	0.000353	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	1.74e-05	0.000351	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.74e-05	0.00035	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—pancreatic cancer	1.72e-05	0.000346	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	1.71e-05	0.000345	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGF—pancreatic cancer	1.69e-05	0.000341	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—pancreatic cancer	1.65e-05	0.000333	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.6e-05	0.000322	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD44—pancreatic cancer	1.58e-05	0.000318	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.56e-05	0.000314	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.56e-05	0.000314	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.55e-05	0.000311	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.55e-05	0.000311	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.54e-05	0.000311	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DPYD—pancreatic cancer	1.52e-05	0.000306	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCG—pancreatic cancer	1.51e-05	0.000305	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	1.51e-05	0.000303	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—pancreatic cancer	1.49e-05	0.0003	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SMAD4—pancreatic cancer	1.49e-05	0.000299	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.47e-05	0.000296	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES1—pancreatic cancer	1.45e-05	0.000292	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—pancreatic cancer	1.45e-05	0.000292	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.44e-05	0.000291	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STK11—pancreatic cancer	1.42e-05	0.000286	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.41e-05	0.000284	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—pancreatic cancer	1.4e-05	0.000283	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.35e-05	0.000272	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	1.34e-05	0.000271	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.33e-05	0.000269	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.31e-05	0.000264	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.31e-05	0.000263	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—pancreatic cancer	1.3e-05	0.000261	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—pancreatic cancer	1.27e-05	0.000256	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.26e-05	0.000254	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—pancreatic cancer	1.22e-05	0.000246	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—pancreatic cancer	1.22e-05	0.000245	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TSC2—pancreatic cancer	1.21e-05	0.000244	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.21e-05	0.000243	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—pancreatic cancer	1.19e-05	0.000239	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.18e-05	0.000238	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	1.18e-05	0.000238	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.18e-05	0.000237	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.16e-05	0.000234	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.14e-05	0.00023	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.13e-05	0.000228	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD44—pancreatic cancer	1.12e-05	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—pancreatic cancer	1.1e-05	0.000221	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000216	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGF—pancreatic cancer	1.06e-05	0.000213	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—pancreatic cancer	1.05e-05	0.000212	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	1.03e-05	0.000207	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—pancreatic cancer	1.02e-05	0.000206	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—pancreatic cancer	1.02e-05	0.000205	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—pancreatic cancer	1.01e-05	0.000204	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—pancreatic cancer	1.01e-05	0.000204	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000203	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—pancreatic cancer	1.01e-05	0.000203	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—pancreatic cancer	9.94e-06	0.0002	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.52e-06	0.000192	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—pancreatic cancer	9.43e-06	0.00019	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—pancreatic cancer	9.42e-06	0.00019	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.41e-06	0.00019	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—pancreatic cancer	9.4e-06	0.000189	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.37e-06	0.000189	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—pancreatic cancer	9.22e-06	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—pancreatic cancer	8.97e-06	0.000181	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.89e-06	0.000179	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—pancreatic cancer	8.89e-06	0.000179	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—pancreatic cancer	8.71e-06	0.000175	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—pancreatic cancer	8.67e-06	0.000175	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—pancreatic cancer	8.66e-06	0.000174	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—pancreatic cancer	8.38e-06	0.000169	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—pancreatic cancer	8.21e-06	0.000165	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	8e-06	0.000161	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—pancreatic cancer	7.89e-06	0.000159	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—pancreatic cancer	7.74e-06	0.000156	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—pancreatic cancer	7.4e-06	0.000149	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—pancreatic cancer	7.28e-06	0.000147	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—pancreatic cancer	7.09e-06	0.000143	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—pancreatic cancer	7.05e-06	0.000142	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD44—pancreatic cancer	6.89e-06	0.000139	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—pancreatic cancer	6.88e-06	0.000139	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCG—pancreatic cancer	6.6e-06	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—pancreatic cancer	6.58e-06	0.000133	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—pancreatic cancer	6.54e-06	0.000132	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.36e-06	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—pancreatic cancer	6.35e-06	0.000128	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—pancreatic cancer	6.33e-06	0.000128	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	6.27e-06	0.000126	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STK11—pancreatic cancer	6.21e-06	0.000125	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—pancreatic cancer	6.14e-06	0.000124	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—pancreatic cancer	5.94e-06	0.00012	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—pancreatic cancer	5.9e-06	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—pancreatic cancer	5.88e-06	0.000118	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—pancreatic cancer	5.81e-06	0.000117	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—pancreatic cancer	5.77e-06	0.000116	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.59e-06	0.000113	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—pancreatic cancer	5.45e-06	0.00011	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.34e-06	0.000108	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—pancreatic cancer	5.12e-06	0.000103	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—pancreatic cancer	5.01e-06	0.000101	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.87e-06	9.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.83e-06	9.73e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—pancreatic cancer	4.63e-06	9.33e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—pancreatic cancer	4.34e-06	8.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—pancreatic cancer	4.21e-06	8.48e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—pancreatic cancer	4.19e-06	8.44e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—pancreatic cancer	4.09e-06	8.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.92e-06	7.89e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.78e-06	7.62e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.45e-06	6.94e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—pancreatic cancer	3.42e-06	6.9e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3e-06	6.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.98e-06	5.99e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.97e-06	5.99e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.59e-06	5.23e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—pancreatic cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.83e-06	3.69e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.5e-06	3.01e-05	CbGpPWpGaD
